Cefixime Tablets USP 400 mg
|Packaging Size||1 x 5 Tablets|
|Manufacturer||DEVLIFE CORPORATION PVT. LTD.|
|Packaging Type||ALU ALU Blister|
|Also gives||Third Party Manufacturing|
|Shelf life||2 Years|
|Country of Origin||Made in India|
Each film coated tablet contains:
Cefixime Trihydrate USP
Eq. to Anhydrous Cefixime ..... 400 mg
Excipients .................................. q.s.
Colour: Quinoline Yellow
Dexime is indicated in the treatment of the following
Upper Respiratory Tract Infections (URTI): e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk.
Lower Respiratory Tract Infection: e.g. bronchitis.
Urinary Tract Infections: e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.
DOSAGE & ADMINISTRATION:
The usual course of treatment is 7 days. This may be continued for up to 14 days if required.
The recommended adult dosage is 200 – 400 mg daily according to the severity of infection, given either as a single dose or in two divided doses
Dexime is not recommended for use in children under 10 years old.
The safety and efficacy of cefixime has not been established in children less than 6 months
In patients whose creatinine clearance is less than 20 mL/min, it is recommended that a dose of 200 mg once daily should not be exceeded
Indicated for ;
Upper Respiratory Tract Infections
Lower Respiratory Tract Infection
Urinary Tract Infections
- Packaging Details: 1 x 5 Tablets in printed carton with Pack Insert.